safe compounded semaglutide FDA issues warning about some versions of for diabetes, weight loss TGA issues safety alert after

However, further robust studies are required to corroborate the findings regarding the role of LC on endometriosis

Additionally, there's a risk of kidney problems

Semaglutide is now well known as the active ingredient in Novo Nordisks blockbuster type 2 diabetes drug Ozempic and weight-loss drug Wegovy, which were approved by the US Food and Drug Administration in 2017 and 2021, respectively

The lesion at the left T56 demonstrated intrinsic T1-hyperintense signal, suggesting internal hemorrhage, as well as heterogeneous T1 and T2 signal with STIR hyperintensity

This overlap makes it challenging to distinguish medication side effects from disease activity and raises questions about tolerability in this patient population